Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

.gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

HTTPS

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Clinicalinfo.HIV.gov logo.
In affiliation with HIV.gov
Main navigation
  • Home
  • About
  • Guidelines
  • Drug Database
  • Glossary
  • News
  • Resources
  • Contact Us
  • English
  • Español (Spanish)
  1. Home
  2. Search Results
Search Results 221 – 240 of 3236
Fidaxomicin
https://clinicalinfo.hiv.gov/drugs/fidaxomicin/patient
Fidaxomicina
https://clinicalinfo.hiv.gov/drugs/fidaxomicin/patient
Fidaxomicin
https://clinicalinfo.hiv.gov/drugs/fidaxomicin/fda-label
Updates to the Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV
https://clinicalinfo.hiv.gov/news/updates-guidelines-prevention-and-treatment-opportunistic-infections-adults-and-adolescents-6
Actualizaciones a las Guías para la Prevención y Tratamiento de Infecciones Oportunistas en Adultos y Adolescentes con VIH
https://clinicalinfo.hiv.gov/news/updates-guidelines-prevention-and-treatment-opportunistic-infections-adults-and-adolescents-6
Recommendations for Use of Antiretroviral Drugs During Pregnancy
https://clinicalinfo.hiv.gov/guidelines/perinatal-hiv-clinical-guidelines/recommendations-use-arv-drugs-during-pregnancy
Antiretroviral Therapy When Trying to Conceive
https://clinicalinfo.hiv.gov/guidelines/perinatal/recommendations-arv-drugs-pregnancy-hiv-conceive
Use of Antiretroviral Drugs to Prevent Perinatal HIV Transmission and Improve Health During Pregnancy
https://clinicalinfo.hiv.gov/guidelines/perinatal/recommendations-arv-drugs-pregnancy-prevent-hiv-transmission-improve-health
The HHS Panel on Antiretroviral Guidelines for Adults and Adolescents with HIV is Accepting Applications for Scientific/Clinical Members
https://clinicalinfo.hiv.gov/news/hhs-panel-antiretroviral-guidelines-adults-and-adolescents-hiv-accepting-applications
Se están aceptando nominaciones de miembros científicos/ clínicos para el Panel del Departamento de Salud y Servicios Humanos (HHS) para las Guías Antirretrovirales para Adultos y Adolescentes con el VIH
https://clinicalinfo.hiv.gov/news/hhs-panel-antiretroviral-guidelines-adults-and-adolescents-hiv-accepting-applications
Overview
https://clinicalinfo.hiv.gov/guidelines/perinatal/antepartum-care
Recommendations for Use of Antiretroviral Drugs During Pregnancy: Overview
https://clinicalinfo.hiv.gov/guidelines/perinatal/recommendations-arv-drugs-pregnancy-overview
Initial Use of Antiretroviral Therapy During Pregnancy
https://clinicalinfo.hiv.gov/guidelines/perinatal/recommendations-arv-drugs-pregnancy-initial-use-antiretroviral-therapy
When Antiretroviral Therapy Is Being Taken When Pregnancy Occurs
https://clinicalinfo.hiv.gov/guidelines/perinatal/recommendations-arv-drugs-pregnancy-art-taken-when-pregnancy-occurs
Previous Experience With Antiretroviral Medications but Not Currently on Antiretroviral Therapy During Current Pregnancy
https://clinicalinfo.hiv.gov/guidelines/perinatal/recommendations-arv-drugs-pregnancy-previous-experience-not-on-art-during-current
Lack of Viral Suppression While on Antiretroviral Therapy in Pregnancy
https://clinicalinfo.hiv.gov/guidelines/perinatal/recommendations-arv-drugs-pregnancy-lack-viral-suppression-on-antiretroviral-therapy
Table 6. What to Start: Initial Antiretroviral Regimens During Pregnancy
https://clinicalinfo.hiv.gov/guidelines/perinatal/recommendations-arv-drugs-pregnancy-what-start-art-never-received
Table 7. Situation-Specific Recommendations for Use of Antiretroviral Drugs During Pregnancy and When Trying to Conceive
https://clinicalinfo.hiv.gov/guidelines/perinatal/recommendations-arv-drugs-pregnancy-situation-specific-conceive
Teratogenicity
https://clinicalinfo.hiv.gov/guidelines/perinatal/recommendations-arv-drugs-pregnancy-teratogenicity
Antiretroviral Drug Regimens and Pregnancy Outcomes
https://clinicalinfo.hiv.gov/guidelines/perinatal/recommendations-arv-drugs-pregnancy-regimens-maternal-neonatal-outcomes

Pagination

  • First page «
  • Previous page ‹
  • …
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Current page 12
  • Page 13
  • Page 14
  • Page 15
  • Page 16
  • …
  • Next page ›
  • Last page »

CONNECT WITH US

Footer menu

  • Home
  • About
  • Guidelines
  • Drug Database
  • Glossary
  • News
  • Resources
  • Contact Us
  • Sponsors
  • Nondiscrimination Notice
  • Accessibility
  • Disclaimers
  • Sitemap
  • Privacy Policy
  • HHS Vulnerability Disclosure

External links

  • HIVinfo.NIH.gov
  • HHS.gov
  • NIH.gov
  • Players & Viewers
  • HHS 508
  • HHS Privacy Policy
  • Whitehouse.gov
  • USA.gov
  • Freedom of Information Act

Provided in collaboration with NIH’s Office of AIDS Research.